Navigation Links
Algae.Tec growth system validated and enters fast growing global nutraceutical market
Date:12/19/2013

Perth, Australia (PRWEB) December 19, 2013

Algae.Tec Limited (ASX: AEB, OTCQX: ALGXY, FWB: GZA:GR) today announced receipt of a Validation Report from Sydney Environmental and Soil Laboratory Pty Ltd (SESL), a National Association of Testing Authorities (NATA) approved company.

Algae.Tec Chairman Roger Stroud is extremely pleased with the results of the validation that confirms the application and production capability of the Algae.Tec system in an industrial setting.

Mr Stroud said the algae yields achieved are of a sufficiently high level to justify the establishment of a new dedicated algae production facility at Nowra, south of Sydney in New South Wales.

With the successful completion of the validation process, Algae.Tec is now focused on commercializing the technology, with the goal of rapidly establishing a strong, profitable revenue base for the company.

To speed up the path to profitability, Algae.Tec has identified the nutraceuticals market estimated to be worth $205 billion by 2017* as a significant opportunity that offers:

  •     Relatively low capital establishment costs
  •     Potential for high gross margins on revenue
  •     Significant and growing market in Asia in particular

“A decision has been made to focus, in the short term, upon the growing of high quality, high value, nutraceuticals, with an immediate focus on Chlorella and B-Carotene algae. Other nutraceutical algae products will follow,” said Stroud.

Nutraceutical are dietary supplements that support physical and mental health.

As part of this strategic opportunity, Algae.Tec has entered into an exclusive Collaborative Agreement with Nutrition Care Laboratories, based in Melbourne, Victoria.

Nutrition Care is a significant manufacturer and marketer of high value nutraceuticals for many of the best know nutraceutical brands in Australia and internationally, with a focus on Asian markets in particular.

The Algae.Tec closed growth system is perfect for nutraceutical products because all inputs can be controlled, producing a consistently high quality product. In addition these Algae.Tec products are free of impurities and all agricultural chemicals, such as pesticides and herbicides.

Chlorella is an increasingly attractive high protein, nutritional food source, which is highly sought after in Asia. B-Carotene is in demand as a nutritional supplement for vision, immunity and overall health.

“This is a significant market opportunity for AlgaeTec. The Asian market in
particular is increasingly prepared to pay a premium for a quality nutraceutical product,” said Stroud.

Anticipated production of Chlorella, and B-Carotene, is expected to be 2,000 tonnes in 2014, up to 4,000 tonnes in 2015, with a target of 8,000 tonnes in 2016, and 10,000 tonnes by 2017.

Indicative wholesale prices for the Chlorella and B-Carotene are currently $16,000 and up to $90,000 per tonne, respectively. The algae is 100% used as the product. A healthy gross margin on revenue is anticipated as capital costs are expected to be in the vicinity of $7,000 per tonne.

The nutraceuticals initiative was prompted by the significantly lower capital required and better anticipated profit margins per tonne of production compared with biofuels, and the very speedy path to production.

Currently, biofuel initiatives are being developed out of the Atlanta facility through the Company's wholly owned subsidiary, Algae Energy Inc.

Sources of capital are expected to be equity, tax rebates and internal cash flow.

The Company has entered into a long term lease at an industrial warehouse complex in Nowra. This will facilitate a rapid start up of production.

Algae.Tec has worked very hard over the past 12 months to commission and validate the Algae.Tec growth system in the Nowra industrial setting. Mr Stroud said this successful validation now launches the company into the commercialisation phase of its development, looking to rapidly deliver positive cash flows.

  • About the nutraceutical market:
The global nutraceuticals product market reached $142.1 billion in 2011 and is expected to reach $204.8 billion by 2017, growing at a CAGR of 6.3%, according to “Nutraceuticals Product Market: Global Market Size, Segment and Country Analysis & Forecasts (2007-2017),” from Transparency Market Research, Albany, NY.
Growth in Asia-Pacific (including Japan) will be second only to the USA by 2017 according to the report.

About Algae.Tec http://www.algaetec.com.au
Algae.Tec Ltd, founded in 2007, is an Australian advanced renewable algae company that has developed a high-yield enclosed algae growth and harvesting system. The Company has offices in Atlanta, Georgia and Perth, Western Australia. The Algae.Tec bioreactor, an enclosed modular engineered technology, is designed to grow non-GMO algae on an industrial scale, and produce algae products including proteins, oils and biofuels. The Algae.Tec solution is less than one tenth the land footprint of pond growth options, while its enclosed module system is designed to deliver the highest yield of algae per hectare, and solves the problem of food-producing land being turned over for biofuel production.

Read the full story at http://www.prweb.com/releases/2013/12/prweb11439668.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Emerging Nations Key to Hematology Testing Growth: Kalorama Report
2. HIV Market - Global and China Forecast, Share, Size, Growth and Industry Analysis (2010 - 2017)
3. Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy And Forecast Research Report 2013
4. Milk Powder Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
5. Global Bioinformatics Market 2014-2018 Industry size, Shares, Research Trends, Growth, Study, Analysis, Forecast
6. Global Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural etc)- Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
7. M3 Global Research Expands Qualitative Research Department- Next Important Step in M3 Group Growth Strategy
8. Activating pathway could restart hair growth in dormant hair follicles, Penn Study suggests
9. Oncology Leads Biosimilars Market Growth to 2018 Forecasts in New Research Report at RnRMarketResearch.com
10. Clarity Health Services Completes $6.6 Million Investment Round on Heels of Triple Digit Year-To-Date Growth
11. Har Vokse: The Clinically Proven Highly Effective Hair Regrowth Treatment Product Now Offers 1 Month Extra Supply for Limited Time!
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to ... “patient engagement.” The patient is doing more than filling out a survey; in many ... is an increasing emphasis in health care and research on the importance of active ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health and Nutrition ... the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market ... can be easily incorporated into liquid products, while reducing costs to end users. , ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  Caris Life Sciences ® , ... the promise of precision medicine, today announced that St. ... Precision Oncology Alliance™ (POA) as its 17 th ... St. Jude Crosson Cancer Institute will help develop standards ... of tumor profiling, making cancer treatment more precise and ...
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
Breaking Medicine Technology: